Glucagon-like peptide-1: difference between revisions

Diff·revision 8 → 9·18:56, 2 Sep 2024

Difference between revision 8 and revision 9 of Glucagon-like peptide-1. 9 lines changed; the page grew by 397 bytes.

Revision 8 — 20:08, 15 Aug 2024 ProglucagonPia (talk) add the reference range with the assay it was established on 5,430 bytes +569	Revision 9 — 18:56, 2 Sep 2024 HalfLifeHavel (talk) move the trial material out of §Physiology into the compound articles 5,827 bytes +397
31	L cells are open-type epithelial cells whose apical surface contacts the lumen, giving them direct access to nutrient stimuli. Secretion is biphasic: an early rise within 10–15 minutes of ingestion, attributed partly to neural and endocrine relay from the proximal gut, followed by a later phase as nutrients reach the ileum and colon.{{r\|holst2007}}	31	L cells are open-type epithelial cells whose apical surface contacts the lumen, giving them direct access to nutrient stimuli. Secretion is biphasic: an early rise within 10–15 minutes of ingestion, attributed partly to neural and endocrine relay from the proximal gut, followed by a later phase as nutrients reach the ileum and colon.{{r\|holst2007}}
32		32
+		33	\| Stimulus class \| Examples \| Relative potency \|
+		34	\|---\|---\|---\|
+		35	\| Carbohydrate \| Glucose, sucrose \| Moderate \|
+		36	\| Lipid \| Long-chain fatty acids, monoacylglycerols \| High \|
+		37	\| Protein \| Peptones, specific amino acids \| Moderate to high \|
+		38	\| Bile acids \| Deoxycholate via TGR5 \| Moderate \|
+		39	\| Short-chain fatty acids \| Products of colonic fermentation \| Low to moderate \|
+		40
33	== References ==	41	== References ==
34	{{reflist}}	42	{{reflist}}
⋮		⋮
45	[[Category:Peptide drugs]]	53	[[Category:Peptide drugs]]
46	[[Category:Appetite regulation]]	54	[[Category:Appetite regulation]]
+		55	[[Category:Pharmacokinetics]]
47		56